Head-and-neck cancer radiotherapy recommendations during the COVID-19 pandemic: Adaptations from the Indian subcontinent
Main Authors: | Shwetabh Sinha, Sarbani Ghosh Laskar, Naveen Mummudi, Ashwini Budrukkar, Monali Swain, Jai Prakash Agarwal |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2020-01-01
|
Series: | Cancer Research, Statistics, and Treatment |
Online Access: | http://www.crstonline.com/article.asp?issn=2590-3233;year=2020;volume=3;issue=3;spage=424;epage=426;aulast=Sinha |
Similar Items
-
Intensity-modulated radiation therapy versus three-dimensional conformal radiotherapy in head and neck squamous cell carcinoma: long-term and mature outcomes of a prospective randomized trial
by: Tejpal Gupta, et al.
Published: (2020-09-01) -
Brachytherapy in head and neck malignancies:
Indian Brachytherapy Society (IBS)
recommendations and guidelines
by: Rajendra Bhalavat, et al.
Published: (2020-10-01) -
Radiotherapy during the COVID-19 pandemic: What we know and what we practice after four months
by: Shwetabh Sinha, et al.
Published: (2020-01-01) -
Clinical outcomes with high-dose-rate surface mould brachytherapy for intra-oral and skin malignancies involving head and neck region
by: Ashwini Budrukkar, et al.
Published: (2017-03-01) -
Systematic review and meta-analyses of intensity-modulated radiation therapy versus conventional two-dimensional and/or or three-dimensional radiotherapy in curative-intent management of head and neck squamous cell carcinoma.
by: Tejpal Gupta, et al.
Published: (2018-01-01)